Persistent IL-10 production is required for glioma growth suppressive activity by Th1-directed effector cells after stimulation with tumor lysate-loaded dendritic cells
/in Glioblastoma, International Publications, IOZK Veröffentlichungen /von 2007-03-15 / J. Neurooncol. 2007 Sep;84(2):131-40Antigenic profiling of glioma cells to generate allogeneic vaccines or dendritic cell-based therapeutics
/in Glioblastoma, International Publications /von 2007-01-15 / Clin. Cancer Res. 2007 Jan;13(2 Pt 1):566-575p53-independent endoplasmic reticulum stress-mediated cytotoxicity of a Newcastle disease virus strain in tumor cell lines
/in Glioblastoma, International Publications, Newcastle Disease Virus /von 2007-01-10 / J. Virol. 2007 Mar;81(6):2817-30[Dendritic cells and gliomas: a hope in immunotherapy?]
/in Glioblastoma, International Publications /von 2006-12-01 / Neurochirurgie 2006 Dec;52(6):555-70Dendritic cell vaccination in patients with malignant gliomas: current status and future directions
/in Glioblastoma, International Publications, IOZK Veröffentlichungen /von 2006-11-01 / Neurosurgery 2006 Nov;59(5):988-99; discussioin 999-1000Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas
/in Glioblastoma, International Publications /von 2006-11-01 / Cancer Res. 2006 Nov;66(21):10247-52Recent advances in immunotherapy for human glioma
/in Glioblastoma, International Publications /von 2006-11-01 / Curr Opin Oncol 2006 Nov;18(6):631-6A phase II clinical study on relapsed malignant gliomas treated with electro-hyperthermia
/in Glioblastoma, Hyperthermia, International Publications /von 2006-11-01 / In Vivo 2006 Nov-Dec;20(6A):721-4Combined treatment of pediatric high-grade glioma with the oncolytic viral strain MTH-68/H and oral valproic acid
/in Brain Tumors in Children, Glioblastoma, International Publications, Newcastle Disease Virus /von 2006-10-01 / APMIS 2006 Oct;114(10):731-43
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de